Jon Congleton, CEO: Mineralys Therapeutics MLYS Sell · Filed 04/15

Trade details

Type: Insider sale
Amount: $422,035.9
Shares · price: 15,730 sh · $26.83 a share
Held after: 689,321 sh
Stock: Mineralys Therapeutics MLYS
Person: Jon CongletonCEO
Trade date: 26/04/13
Filed: 26/04/15
Days to filing: 2 days

Sold 2.2% of holdings

Share of holding sold: 2.2%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 03/14~05/13

Jon Congleton's recent trades

Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$291.4K
10,700 sh
$291.4K
Filed 07/13
Traded 07/13
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$1.5M
58,000 sh
$1.5M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$455.9K
17,000 sh
$455.9K
Filed 06/30
Traded 06/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2M
75,000 sh
$2M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$422K
15,730 sh
$422K
Filed 04/13
Traded 04/13